Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial - Concepedia

Concepedia

Publication | Open Access

Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial

DOI Full Paper Access

82

Citations

50

References

2022

Year

Joseph P. Casazza, Evan M. Cale, Sandeep Narpala, Galina V. Yamshchikov, Emily E. Coates, Cynthia S. Hendel, Laura Novik, LaSonji A. Holman, Alicia T. Widge, Preeti Apte,

Nature Medicine

VaccinationNeutralizing AntibodyHuman RetrovirusImmunologyAntiviral TherapyAntiviral ResponsePhase 1Antiviral DrugHivImmunotherapyMedicineAav8 Delivery

References

	Year	Citations

Page 1

Page 1